Skip to content

Oxiconazole

Azole Antifungal — DERMATOLOGICALS

Also known as: oxiconazole nitrate, oxyconazole, Ro 13-8996

OfpFDA approvedATC D01AC11ATC G01AF17

Data last refreshed: (DrugCentral release 2024-11-01)

Key facts

Oxiconazole is an ofp drug in the Azole Antifungal class catalogued in DrugCentral. It was first approved by the FDA in 1988. DrugCentral lists 26 molecular targets, including CYP2C19, CYP3A4 and ADORA3. Recorded indications include Pityriasis versicolor, Tinea corporis, Tinea cruris and Tinea pedis.

  • Approval status: ofp (first approved 1988 by the FDA).
  • Drug class: Azole Antifungal.
  • Molecular targets: CYP2C19, CYP3A4, ADORA3 and SLC6A4 (26 listed in DrugCentral).
  • Indications: Pityriasis versicolor, Tinea corporis, Tinea cruris and Tinea pedis.
  • ATC code: D01AC11 (Imidazole and triazole derivatives).
  • Molecular formula: C18H13Cl4N3O; molecular weight 429.12 g/mol.

Indications & contraindications

Drug–disease relationships curated by DrugCentral (OMOP / SNOMED concepts).

Indications (4)

  • Pityriasis versicolor
  • Tinea corporis
  • Tinea cruris
  • Tinea pedis

Contraindications (1)

  • Skin irritation

Mechanism & targets

Established pharmacologic classAzole Antifungal

Molecular targets (26)

TargetGeneActionActivity
Cytochrome P450 2C19CYP2C19unknownIC50 7.40
Cytochrome P450 3A4CYP3A4unknownIC50 7.05
Adenosine receptor A3ADORA3unknownKi 6.45
Sodium-dependent serotonin transporterSLC6A4unknownKi 6.37
Alpha-2C adrenergic receptorADRA2CunknownKi 6.22
Thromboxane-A synthaseTBXAS1unknownIC50 6.21
D(3) dopamine receptorDRD3unknownKi 6.17
Muscarinic acetylcholine receptor M3CHRM3unknownKi 6.02
Cytochrome P450 2D6CYP2D6unknownIC50 6.00
Substance-K receptorTACR2unknownKi 5.97
Muscarinic acetylcholine receptor M1CHRM1unknownKi 5.94
5-hydroxytryptamine receptor 2AHTR2AunknownKi 5.92
Alpha-2A adrenergic receptorADRA2AunknownKi 5.82
Alpha-2B adrenergic receptorADRA2BunknownKi 5.78
Delta-type opioid receptorOPRD1unknownKi 5.73
Sodium-dependent noradrenaline transporterSLC6A2unknownKi 5.72
D(1A) dopamine receptorDRD1unknownKi 5.68
Sodium-dependent dopamine transporterSLC6A3unknownKi 5.68
5-hydroxytryptamine receptor 2BHTR2BunknownKi 5.53
Cytochrome P450 2C9CYP2C9unknownIC50 5.52

Regulatory approvals (1)

DateAgencyMarketed asApplicantOrphan
1988-12-30FDA—FOUGERA PHARMS

ATC classification

ATC codeTherapeutic hierarchy
D01AC11DERMATOLOGICALS › ANTIFUNGALS FOR DERMATOLOGICAL USE › ANTIFUNGALS FOR TOPICAL USE › Imidazole and triazole derivatives
G01AF17GENITO URINARY SYSTEM AND SEX HORMONES › GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS › ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS › Imidazole derivatives

Chemical structure

Full physicochemical, ADMET and 3D-structure analysis of Oxiconazole is on its molecule page.

Molecular formulaC18H13Cl4N3O
Molecular weight429.12 g/mol
CAS number64211-45-6
InChIKeyQRJJEGAJXVEBNE-HKOYGPOVSA-N
PubChem CID5353853
ClC1=CC(Cl)=C(CO\N=C(/CN2C=CN=C2)C2=C(Cl)C=C(Cl)C=C2)C=C1

Frequently asked questions

Answers are generated from the structured data on this page, not written by hand.

What is Oxiconazole used for?

DrugCentral lists the following indications for Oxiconazole: Pityriasis versicolor, Tinea corporis, Tinea cruris and Tinea pedis.

How does Oxiconazole work?

Its molecular targets in DrugCentral include CYP2C19, CYP3A4, ADORA3 and SLC6A4.

When was Oxiconazole first approved?

Oxiconazole was first approved by the FDA in 1988.

What drug class does Oxiconazole belong to?

Oxiconazole is in the Azole Antifungal class.

What is the chemical formula of Oxiconazole?

Oxiconazole has the molecular formula C18H13Cl4N3O and a molecular weight of 429.12 g/mol.

Browse: all drugs starting with O · drug guides by category · protein targets A–Z.

Sources

How this page is built: methodology · editorial policy & corrections.

For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.

Quick facts

StatusOFP
First approval1988-12-30
AgencyFDA
Targets26
Indications4
FormulaC18H13Cl4N3O
DrugCentral ID3408
Interactive profile